scorecardresearch

Pharma

Union Minister Mandaviya urges pharma industry to make India a manufacturing hub

Union Minister Mandaviya urges pharma industry to make India a manufacturing hub

Oct 27, 2021

He said that the government is looking to make the country a pharma hub and noted that it is in the process of setting up three bulk drug parks in the country.

Glenmark claims that Remogliflozin + Vildagliptin + Metformin combination will significantly improve access and bring a world-class and well-researched combination product at an affordable price to patients in India.

Glenmark becomes the first company to launch Type 2 Diabetes fixed-dose combination drug in India

Oct 26, 2021

Glenmark received approval for the drug from the Drug Controller General of India for manufacturing and marketing in late September 2021.

LupinLife has signed Hrithik Roshan as brand ambassador of Be One, its Ayurvedic energy supplement.

LupinLife ropes in Hrithik Roshan as brand ambassador for its Ayurvedic energy supplement

Oct 22, 2021

Be One is an Ayurvedic health and wellness supplement specially developed for men comprising ingredients like Ashwagandha, Pippali and Shatavari in a single vegetarian capsule.

Abiraterone Acetate is a drug used for treating prostate cancer

Dr Reddy's launches an anti-cancer drug in China

Oct 14, 2021

Hyderabad-based Dr Reddy's Laboratories has become the first Indian pharmaceutical company to launch an anti-cancer drug in the Chinese market.

 "After the successful development and commercialisation of various COVID-19 drugs such as Oseltamivir, Remdesivir Everest Organics is on its path of expansion of this portfolio," Chief Executive Officer Srikakarlapudi Sirisha said in a statement.

COVID-19: Everest Organics starts making ingredient for Merck's molnupiravir drug

Oct 12, 2021

Merck has separately entered into voluntary licensing agreements with at least eight Indian generic drugmakers for molnupiravir, to turn the country into a manufacturing hub for the drug.

Glenmark logo

Glenmark Pharma launches Tavulus for COPD treatment in Spain

Oct 11, 2021

COPD is a long-term condition that causes inflammation in the lungs, damaging the lung tissue and narrowing the airways, all of which make breathing difficult. Glenmark will sell the powder under the brand name Tavulus.

Cipla to sell Eli Lilly's Trulicity, Humalog diabetes treatments in India

Oct 04, 2021

Lilly will transfer its rights in India to sell, promote and distribute its Trulicity and Humalog products, while continuing to maintain its existing operating model for the remaining portfolio of its products

Glenmark is recalling 6,552 bottles of Chlorzoxazone tablets (in strengths of USP 375 mg and 750 mg) due to CGMP deviations

Drug makers Glenmark, Aurobindo recall multiple products in US

Oct 03, 2021

Glenmark is recalling 28,658 cartons of Fulvestrant injection (250 mg/5 ml), a medicine used to treat breast cancer, due to "lack of assurance of sterility", the US health regulator noted in the report

The three contenders in the race are Pfizer and its rivals, Merck & Co Inc and Swiss pharmaceutical Roche Holding AG

Three pharma cos in race to find COVID-19 treatment pill; results likely by 2021-end

Sep 25, 2021

The medication being produced by Merck & Co. and Ridgeback Biotherapeutics is called molnupiravir, while two other candidates in the works are PF-07321332, and AT-527 by Pfizer and Roche and Atea Pharmaceuticlas

USFDA conducted an on-site pre-approval inspection of the company's Malaysian subsidiary Biocon Sdn Bhd's manufacturing facility (Representational Image)

USFDA issues six observations post inspection of Biocon's Malaysian arm manufacturing facility

Sep 25, 2021

A Biocon spokesperson said the company is confident of addressing the observations through procedural enhancements and an appropriate Corrective and Preventive Action Plan (CAPA)

Zydus Cadila has stated that the targeted production of the ZyCoV-D vaccine from the Dharwad facility will be mutually agreed upon by both parties

Zydus Cadila inks deal with Shipa Medicare for ZyCoV-D COVID-19 vaccine production

Sep 24, 2021

Shilpa Medicare Limited will produce the ZyCoV-D COVID-19 vaccine at its biologics R&D and manufacturing centre in Dharwad, Karnataka